Valuation Photocure ASA OTC Markets

Stocks

Market Closed - OTC Markets 16:24:53 11/09/2026 BST			5-day change	1st Jan Change
5.650 ^USD	-5.99%		0.00%	-19.29%

08-16	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
08-14	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,319	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-30.57%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,150	1,162	1,159
Change	-	6.28%	-40.61%	-11.53%	19.77%	-30.76%	1.04%	-0.23%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	17.3x	62.8x	42.2x
PBR	-	-	-	-	-	3.66x	3.36x	3.16x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.9x	0.9x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2x	1.98x	1.83x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.75x	1.74x	1.61x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	7.54x	12.2x	13.4x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	10.4x	27.4x	21.2x
EV / FCF	113x	-469x	35.4x	18.4x	95x	17.4x	103x	47.6x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	5.74%	0.98%	2.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	2.83	0.78	1.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	658.3	666.3	720.3
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	152.5	95	86.5
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	110.3	42.33	54.67
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	76.33	21	31.67
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-169	-157	-159.7
Reference price ²	102.70	106.80	67.40	62.00	71.40	49.00	49.00	49.00
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,917	-	-
Announcement Date	23/02/22	23/02/23	21/02/24	19/02/25	18/02/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.65x	12.19x	24.78x	0.59%	1,055B
JOHNSON & JOHNSON	30.17x	6.71x	18.78x	1.98%	654B
ABBVIE INC.	33.43x	7.82x	16.17x	2.59%	467B
ROCHE HOLDING AG	19.59x	4.78x	11.84x	2.78%	348B
NOVARTIS AG	20.4x	5.31x	13.17x	3.01%	275B
ASTRAZENECA PLC	21.19x	4.39x	12.5x	2.01%	258B
AMGEN INC.	26.19x	6.82x	12.15x	2.43%	224B
GILEAD SCIENCES, INC.	-45.65x	6.64x	25.94x	2.18%	187B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	171B
Average	16.70x	6.53x	15.99x	2.45%	404.26B
Weighted average by Cap.	24.18x	7.87x	18.13x	1.96%